<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Results</title>
    <link rel="stylesheet" href="./lib/css/styles.css">
</head>
<body class="results">
<p><strong>Asymptomatic patient. Low risk for coronary artery disease. Initial imaging.</strong></p>
Advice from ACR  - https://acsearch.acr.org/docs/3082570/Narrative/
<p><strong>&nbsp;</strong></p>
<p><strong>No Imaging is usually appropriate.</strong></p>
<p><strong>&nbsp;</strong></p>
<p><strong>CT Coronary Calcium</strong></p>
<p>The CAC score first became available and validated with electron beam CT, and in the modern era, MDCT is used to acquire this data. Several multicenter trials have assessed the use of CAC in asymptomatic patients at intermediate risk for CAD. In the Multi-Ethnic Study of Atherosclerosis (MESA), Joshi et al [14] followed 6,814 participants</p>
<p>ACR Appropriateness Criteria&reg;5 Asymptomatic Patient at Risk for CAD including 13% with a CAC score &gt;100 and 34% with a nonzero CAC score with low risk over a period of 10.4 years and found an event rate of 2.4% (33 events). CAC was present in 76% of participants with an event. In the multivariate analysis, only CAC &gt;100 was predictive of coronary heart disease [14]. Recently, in a large cohort of 14,169 low-risk patients with a family history of CAD, Dudum et al showed that a calcium score of &gt;100 had a 2.2 times higher risk for all-cause mortality, 4.3 times higher cardiovascular specific mortality, and 10.4 times higherrisk of coronary heart disease, than patients with a zero calcium score [15,16]. Mitchell et al [17] evaluated 23,637 subjects with a mean age of 50.0 &plusmn; 8.5 years and low burden of traditional risk factors, they noted relative adjusted subhazard ratio for CAC 1 to 100, 101 to 400, and &gt;400 was 2.2, 3.8, and 5.9 for myocardial infarction; 1.2, 1.4, and 1.9 for stroke; 1.4, 2.0, and 2.8 for major adverse cardiovascular events (MACE); and 1.2, 1.5 and 2.1 for death (P&nbsp; &lt;&nbsp; .0001) over&nbsp; a&nbsp; median&nbsp; follow-up&nbsp; period&nbsp; of&nbsp; 11.4&nbsp; years.&nbsp; Among&nbsp; subjects&nbsp; without&nbsp; traditional&nbsp; risk&nbsp; factors&nbsp; (n = 6,208; mean age 43.8 &plusmn; 4.4 years), the presence of any CAC (&gt;0; n = 848) was associated with an increased risk of MACE&nbsp; (adjusted&nbsp; subhazard&nbsp; ratio:&nbsp; 1.67;&nbsp; 95%&nbsp; confidence&nbsp; interval&nbsp; [CI],&nbsp; 1.16&nbsp; to&nbsp; 2.39)&nbsp; noting&nbsp; the&nbsp; fact&nbsp; that&nbsp; young&nbsp; individuals without traditional risk factors are typically not offered preventive therapy with statins. Carr et al [18]prospectively enrolled a much younger cohort of 3,043 patients with mean [SD] age 40.3 [3.6] years in the Coronary Artery Risk Development in Young Adults (CARDIA) study and noted that 10.2% of patients had CAC, with a geometric&nbsp; mean&nbsp; Agatston&nbsp; score&nbsp; of&nbsp; 21.6&nbsp; (interquartile&nbsp; range,&nbsp; 17.3&ndash;26.8).&nbsp; During&nbsp; 12.5&nbsp; years&nbsp; of&nbsp; follow-up,&nbsp; 57&nbsp; coronary heart disease events and 108 cardiovascular events were observed. After adjusting for demographics, risk factors,&nbsp; and&nbsp; treatments,&nbsp; patients with&nbsp; any&nbsp; CAC&nbsp; experienced&nbsp; a&nbsp; 5-fold&nbsp; increase&nbsp; in&nbsp; coronary&nbsp; heart&nbsp; disease&nbsp; events(hazard ratio [HR], 5.0; 95% CI, 2.8&ndash;8.7) and 3-fold increase in cardiovascular events (HR, 3.0; 95% CI, 1.9&ndash;4.7),and those with a CAC score of &ge;100 had an incidence of 22.4 deaths per 100 participants (HR, 3.7; 95% CI, 1.5&ndash;10.0).</p>
<p><strong>CTA Coronary Arteries</strong></p>

<p>There is no relevant literature supporting the use of coronary CTA (CCTA) in asymptomatic patients at low risk ofCAD. Choi et al [19] identified atherosclerotic plaques in 215 of 1,000 middle-aged asymptomatic patients with 2% prevalence of plaque in the low-risk group.</p>
<p>&nbsp;</p>
<p><strong>US Echocardiography Transthoracic Resting</strong></p>
<p>There is no relevant literature supporting the use of transthoracic echocardiography (TTE) resting in asymptomatic patients at low risk of CAD.</p>
<p><strong>US Echocardiography Transthoracic Stress</strong></p>
<p>There is no relevant literature supporting the use of TTE stress in asymptomatic patients at low risk of CAD. The sensitivity and specificity of the test is 72% to 83% and 84% to 95%, respectively, for identification of ischemic myocardium and has been validated only in elevated risk populations [20].</p>
<p><strong>MRA Coronary Arteries</strong></p>
<p>There are very limited data on the utility of MRA in asymptomatic patients, which demonstrated a low yield in a small cohort of nonrandomized asymptomatic self-referred patients. In this cohort of 341 patients, 3.8% were found to&nbsp; have&nbsp; significant&nbsp; CAD&nbsp; &ge;50%&nbsp; stenosis&nbsp; in&nbsp; a&nbsp; protocol&nbsp; that&nbsp; also&nbsp; included&nbsp; MRA, MRI&nbsp; perfusion,&nbsp; and&nbsp; delayed-enhancement imaging; 0.9% of the cohort underwent percutaneous coronary intervention after CAD was detected by&nbsp; cardiac&nbsp; MRI&nbsp; and&nbsp; MRA&nbsp; and was&nbsp; found&nbsp; to&nbsp; have&nbsp; good&nbsp; correlation&nbsp; with&nbsp; stress&nbsp; perfusion MRI &nbsp;in&nbsp; the&nbsp; 13&nbsp; positive&nbsp; patients, 3 of which were confirmed with invasive angiography [21].</p>
<p>&nbsp;</p>
<p><strong>MRI Heart Function with Stress</strong></p>
<p>&nbsp;</p>
<p>There is no relevant literature supporting the use of MRI heart function with stress in asymptomatic patients at low risk of CAD.</p>
<p><strong>MRI Heart Function and Morphology</strong></p>
<p>Weir-McCall&nbsp; et&nbsp; al&nbsp; [22]&nbsp; demonstrated an&nbsp; overall&nbsp; low&nbsp; utility&nbsp; of&nbsp; resting&nbsp; MRI&nbsp; via&nbsp; abnormal&nbsp; late&nbsp; gadolinium&nbsp; enhancement in asymptomatic low-risk volunteers (0.67% of whom were found to have abnormalities, including myocardial infarction), with only 0.2% of volunteers having a previously unrecognized myocardial infarction.Radiography ChestThere is no relevant literature to support the use of chest radiographs to evaluate asymptomatic patients at low risk of CAD.</p>
<p><strong>SPECT/CT MPI Rest and Stress</strong></p>
<p>There&nbsp; is&nbsp; no&nbsp; relevant&nbsp; literature supporting the&nbsp; use&nbsp; of&nbsp; single-photon&nbsp; emission computed&nbsp; tomography&nbsp; (SPECT)/CT myocardial perfusion imaging (MPI)&nbsp;&nbsp; rest and stress in asymptomatic patients at low risk of CAD. Stress SPECT sensitivity&nbsp; and&nbsp; specificity&nbsp; for&nbsp; detection&nbsp; of&nbsp; obstructive&nbsp; CAD&nbsp; (&ge;50%&nbsp; diameter&nbsp; stenosis)&nbsp; are 74%&nbsp; and&nbsp; 79%, respectively, in symptomatic patients [23].</p></body>
<p><strong>References</strong></p>
<ol>
    <li>Cooper R,&nbsp; Cutler&nbsp; J,&nbsp; Desvigne-Nickens&nbsp; P,&nbsp; et&nbsp; al.&nbsp; Trends&nbsp; and&nbsp; disparities&nbsp; in&nbsp; coronary&nbsp; heart&nbsp; disease,&nbsp; stroke,&nbsp; and&nbsp; other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation2000;102:3137-47.</li>
    <li>Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2010;56:e50-103.</li>
    <li>Grundy SM,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stone&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NJ,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bailey&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AL,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; et&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; al.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guideline&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Management&nbsp; of&nbsp; Blood&nbsp; Cholesterol:&nbsp; A&nbsp; Report&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology/American&nbsp; Heart&nbsp; Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019;73:e285-e350.</li>
    <li>Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA2003;290:891-7.</li>
    <li>Goff DC, Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a&nbsp; report&nbsp; of&nbsp; the&nbsp; American &nbsp;College&nbsp; of&nbsp; Cardiology/American&nbsp; Heart&nbsp; Association&nbsp; Task&nbsp; Force&nbsp; on&nbsp; Practice&nbsp; Guidelines. J Am Coll Cardiol2014;63:2935-59.</li>
    <li>Wilson SR,&nbsp; Lin&nbsp; FY,&nbsp; Min&nbsp; JK.&nbsp; Role&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; score&nbsp; and&nbsp; coronary&nbsp; CT&nbsp; angiography&nbsp; in&nbsp; the&nbsp; diagnosis&nbsp; and&nbsp; risk&nbsp; stratification&nbsp; of&nbsp; individuals&nbsp; with&nbsp; suspected&nbsp; coronary&nbsp; artery&nbsp; disease.&nbsp; Curr&nbsp; Cardiol&nbsp; Rep2011;13:271-9.</li>
    <li>Perez de Isla L, Alonso R, Muniz-Grijalvo O, et al. Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study. J Clin Lipidol2018;12:948-57.</li>
    <li>Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med2008;358:1336-45.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&nbsp; Appropriateness&nbsp; Criteria&reg;:&nbsp; Acute&nbsp; Nonspecific&nbsp; Chest&nbsp; Pain&mdash;Low Probability of Coronary Artery Disease. Available at: https://acsearch.acr.org/docs/69401/Narrative/. Accessed September 30, 2020.</li>
    <li>Shah AB, Kirsch J, Bolen MA, et al. ACR Appropriateness Criteria&reg; Chronic Chest Pain-Noncardiac Etiology Unlikely-Low to Intermediate Probability of Coronary Artery Disease. J Am Coll Radiol2018;15:S283-S90.</li>
    <li>Akers SR, Panchal V, Ho VB, et al. ACR Appropriateness Criteria&reg; Chronic Chest Pain-High Probability of Coronary Artery Disease. J Am Coll Radiol2017;14:S71-S80.</li>
    <li>Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol1987;59:23C-30C.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&ndash;NASCI&ndash;SIR&ndash;SPR&nbsp; Practice&nbsp; Parameter&nbsp; for&nbsp; the&nbsp; Performance&nbsp; and&nbsp; Interpretation&nbsp; of&nbsp; Body&nbsp; Computed&nbsp; Tomography&nbsp; Angiography&nbsp; (CTA).&nbsp; Available&nbsp; at:&nbsp; https://www.acr.org/-/media/ACR/Files/Practice-Parameters/body-cta.pdf. Accessed September 30, 2020.</li>
    <li>Joshi PH, Patel B, Blaha MJ, et al. Coronary artery Calcium predicts Cardiovascular events in participants with a low&nbsp;&nbsp; lifetime&nbsp;&nbsp; risk&nbsp;&nbsp; of&nbsp;&nbsp; Cardiovascular&nbsp;&nbsp; disease:&nbsp;&nbsp; The&nbsp;&nbsp; Multi-Ethnic&nbsp;&nbsp; Study&nbsp;&nbsp; of&nbsp;&nbsp; Atherosclerosis&nbsp;&nbsp; (MESA).&nbsp;&nbsp; Atherosclerosis2016;246:367-73.</li>
    <li>Hecht H, Blaha MJ, Berman DS, et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr2017;11:157-68.</li>
    <li>Dudum R,&nbsp; Dzaye&nbsp; O,&nbsp; Mirbolouk&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; artery&nbsp; calcium&nbsp; scoring&nbsp; in&nbsp; low&nbsp; risk&nbsp; patients&nbsp; with&nbsp; family&nbsp; history of coronary heart disease: Validation of the SCCT guideline approach in the coronary artery calcium consortium. J Cardiovasc Comput Tomogr2019;13:21-25.</li>
    <li>Mitchell JD,&nbsp; Paisley&nbsp; R,&nbsp; Moon&nbsp; P,&nbsp; Novak&nbsp; E,&nbsp; Villines&nbsp; TC.&nbsp; Coronary&nbsp; Artery&nbsp; Calcium&nbsp; and&nbsp; Long-Term&nbsp; Risk&nbsp; of&nbsp; Death,&nbsp; Myocardial&nbsp; Infarction,&nbsp; and&nbsp; Stroke:&nbsp; The&nbsp; Walter&nbsp; Reed&nbsp; Cohort&nbsp; Study.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2018;11:1799-806.</li>
    <li>Carr JJ, Jacobs DR, Jr., Terry JG, et al. Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death. JAMA Cardiol2017;2:391-99.</li>
    <li>Choi EK,&nbsp; Choi&nbsp; SI,&nbsp; Rivera&nbsp; JJ,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; computed&nbsp; tomography&nbsp; angiography&nbsp; as&nbsp; a&nbsp; screening&nbsp; tool&nbsp; for&nbsp; the&nbsp; detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol2008;52:357-65.</li>
    <li>Heijenbrok-Kal MH,&nbsp; Fleischmann&nbsp; KE,&nbsp; Hunink&nbsp; MG.&nbsp; Stress&nbsp; echocardiography,&nbsp; stress&nbsp; single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J2007;154:415-23.</li>
    <li>Song KD, Kim SM, Choe YH, et al. Integrated cardiac magnetic resonance imaging with coronary magnetic resonance angiography,&nbsp; stress-perfusion,&nbsp; and&nbsp; delayed-enhancement&nbsp; imaging&nbsp; for&nbsp; the&nbsp; detection&nbsp; of&nbsp; occult&nbsp; coronary artery disease in asymptomatic individuals. Int J Cardiovasc Imaging2015;31 Suppl 1:77-89.</li>
    <li>Weir-McCall JR, Fitzgerald K, Papagiorcopulo CJ, et al. Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis. Eur Heart J Cardiovasc Imaging2017;18:657-62.</li>
    <li>Mordi IR,&nbsp; Badar&nbsp; AA,&nbsp; Irving&nbsp; RJ,&nbsp; Weir-McCall&nbsp; JR,&nbsp; Houston&nbsp; JG,&nbsp; Lang&nbsp; CC.&nbsp; Efficacy&nbsp; of&nbsp; noninvasive&nbsp; cardiac&nbsp; imaging&nbsp; tests&nbsp; in&nbsp; diagnosis&nbsp; and&nbsp; management&nbsp; of&nbsp; stable&nbsp; coronary&nbsp; artery&nbsp; disease.&nbsp; Vasc&nbsp; Health&nbsp; Risk&nbsp; Manag2017;13:427-37.</li>
    <li>Kondos GT,&nbsp; Hoff&nbsp; JA,&nbsp; Sevrukov&nbsp; A,&nbsp; et&nbsp; al.&nbsp; Electron-beam&nbsp; tomography&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; and&nbsp; cardiac&nbsp; events:&nbsp; a&nbsp; 37-month&nbsp; follow-up&nbsp; of&nbsp; 5635&nbsp; initially&nbsp; asymptomatic&nbsp; low-&nbsp;&nbsp; to&nbsp; intermediate-risk&nbsp; adults.&nbsp; Circulation2003;107:2571-6.</li>
    <li>Shaw LJ,&nbsp; Raggi&nbsp; P,&nbsp; Schisterman&nbsp; E,&nbsp; Berman&nbsp; DS,&nbsp; Callister&nbsp; TQ.&nbsp; Prognostic&nbsp; value&nbsp; of&nbsp; cardiac&nbsp; risk&nbsp; factors&nbsp; and&nbsp; coronary artery calcium screening for all-cause mortality. Radiology2003;228:826-33.</li>
    <li>Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol2007;49:1860-70.</li>
    <li>Okwuosa TM, Greenland P, Ning H, Liu K, Lloyd-Jones DM. Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging2012;5:923-30.</li>
    <li>Gibson AO, Blaha MJ, Arnan MK, et al. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging2014;7:1108-15.</li>
    <li>Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA2010;303:1610-6.</li>
    <li>Erbel R,&nbsp; Mohlenkamp&nbsp; S,&nbsp; Moebus&nbsp; S,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; risk&nbsp; stratification,&nbsp; discrimination,&nbsp; and&nbsp; reclassification&nbsp; improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol2010;56:1397-406.</li>
    <li>Mulders TA, Taraboanta C, Franken LC, et al. Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease. Atherosclerosis2016;245:155-60.</li>
    <li>Nasir K, Rubin J, Blaha MJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging2012;5:467-73.</li>
    <li>Di Cesare E, Patriarca L, Panebianco L, et al. Coronary computed tomography angiography in the evaluation of intermediate risk asymptomatic individuals. Radiol Med2018;123:686-94.</li>
    <li>Picano E, Molinaro S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound2008;6:30.</li>
    <li>Cruz G,&nbsp; Atkinson&nbsp; D,&nbsp; Henningsson&nbsp; M,&nbsp; Botnar&nbsp; RM,&nbsp; Prieto&nbsp; C.&nbsp; Highly&nbsp; efficient&nbsp; nonrigid&nbsp; motion-corrected&nbsp; 3D&nbsp; whole-heart coronary vessel wall imaging. Magn Reson Med2017;77:1894-908.</li>
    <li>Moghari MH,&nbsp; Roujol&nbsp; S,&nbsp; Henningsson&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Three-dimensional&nbsp; heart&nbsp; locator&nbsp; for&nbsp; whole-heart&nbsp; coronary&nbsp; magnetic resonance angiography. Magn Reson Med2014;71:2118-26.</li>
    <li>Schwitter J,&nbsp; Wacker&nbsp; CM,&nbsp; Wilke&nbsp; N,&nbsp; et&nbsp; al.&nbsp; MR-IMPACT&nbsp; II:&nbsp; Magnetic&nbsp; Resonance&nbsp; Imaging&nbsp; for&nbsp; Myocardial&nbsp; Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission&nbsp; computed&nbsp; tomography&nbsp; for&nbsp; the&nbsp; detection&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; disease:&nbsp; a&nbsp; comparative&nbsp; multicentre,&nbsp; multivendor trial. Eur Heart J2013;34:775-81.</li>
    <li>Hendel RC,&nbsp; Abbott&nbsp; BG,&nbsp; Bateman&nbsp; TM,&nbsp; et&nbsp; al.&nbsp; The&nbsp; role&nbsp; of &nbsp;radionuclide&nbsp; myocardial&nbsp; perfusion&nbsp; imaging&nbsp; for&nbsp; asymptomatic individuals. J Nucl Cardiol2011;18:3-15.</li>
    <li>Multimodality Writing&nbsp;&nbsp; Group&nbsp;&nbsp; for&nbsp;&nbsp; Stable&nbsp;&nbsp; Ischemic&nbsp;&nbsp; Heart&nbsp;&nbsp; Disease,&nbsp;&nbsp; Wolk&nbsp;&nbsp; MJ,&nbsp;&nbsp; Bailey&nbsp;&nbsp; SR,&nbsp;&nbsp; et&nbsp;&nbsp; al.&nbsp;&nbsp; ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS&nbsp; 2013&nbsp; multimodality&nbsp; appropriate&nbsp; use&nbsp; criteria&nbsp; for&nbsp; the&nbsp; detection&nbsp; and&nbsp; risk&nbsp; assessment&nbsp; of&nbsp; stable&nbsp; ischemic&nbsp; heart&nbsp; disease:&nbsp; a&nbsp; report&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of&nbsp; Echocardiography,&nbsp; American&nbsp; Society&nbsp; of&nbsp; Nuclear&nbsp; Cardiology,&nbsp; Heart&nbsp; Failure&nbsp; Society&nbsp; of&nbsp; America,&nbsp; Heart&nbsp; Rhythm&nbsp; Society,&nbsp; Society&nbsp; for&nbsp; Cardiovascular&nbsp; Angiography&nbsp; and&nbsp; Interventions,&nbsp; Society&nbsp; of&nbsp; Cardiovascular&nbsp; Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Card Fail2014;20:65-90.</li>
    <li>Sarwar A,&nbsp; Shaw&nbsp; LJ,&nbsp; Shapiro&nbsp; MD,&nbsp; et&nbsp; al.&nbsp; Diagnostic&nbsp; and&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; absence&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; calcification. JACC Cardiovasc Imaging2009;2:675-88.</li>
    <li>Blaha MJ, Budoff MJ, DeFilippis AP, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet2011;378:684-92.</li>
    <li>Cho I, Chang HJ, B OH, et al. Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) study. Eur Heart J2015;36:501-8.</li>
    <li>Dedic A,&nbsp; Ten&nbsp; Kate&nbsp; GJ,&nbsp; Roos&nbsp; CJ,&nbsp; et&nbsp; al.&nbsp; Prognostic&nbsp; Value&nbsp; of&nbsp; Coronary&nbsp; Computed&nbsp; Tomography&nbsp; Imaging&nbsp; in&nbsp; Patients at High Risk Without Symptoms of Coronary Artery Disease. Am J Cardiol2016;117:768-74.</li>
    <li>Plank F,&nbsp; Friedrich&nbsp; G,&nbsp; Dichtl&nbsp; W,&nbsp; et&nbsp; al.&nbsp; The&nbsp; diagnostic&nbsp; and&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; coronary&nbsp; CT&nbsp; angiography&nbsp; in&nbsp; asymptomatic high-risk patients: a cohort study. Open Heart2014;1:e000096.</li>
    <li>Min JK,&nbsp; Labounty&nbsp; TM,&nbsp; Gomez&nbsp; MJ,&nbsp; et&nbsp; al.&nbsp; Incremental&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; coronary&nbsp; computed&nbsp; tomographic&nbsp; angiography&nbsp; over&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; score&nbsp; for&nbsp; risk&nbsp; prediction&nbsp; of&nbsp; major&nbsp; adverse&nbsp; cardiac&nbsp; events&nbsp; in&nbsp; asymptomatic diabetic individuals. Atherosclerosis2014;232:298-304.</li>
    <li>Muhlestein JB, Lappe DL, Lima JA, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA2014;312:2234-43.</li>
    <li>Guaricci AI,&nbsp; Lorenzoni&nbsp; V,&nbsp; Guglielmo&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Prognostic&nbsp; relevance&nbsp; of&nbsp; subclinical&nbsp; coronary&nbsp; and&nbsp; carotid&nbsp; atherosclerosis in a diabetic and nondiabetic asymptomatic population. Clin Cardiol2018;41:769-77.</li>
    <li>Halon DA, Lavi I, Barnett-Griness O, et al. Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic&nbsp; Type&nbsp; 2&nbsp; Diabetes:&nbsp; A&nbsp; Long-Term &nbsp;Observational&nbsp; Study.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2019;12:1353-63.</li>
    <li>Beller E,&nbsp; Meinel&nbsp; FG,&nbsp; Schoeppe&nbsp; F,&nbsp; et&nbsp; al.&nbsp; Predictive&nbsp; value&nbsp; of&nbsp; coronary&nbsp; computed&nbsp; tomography&nbsp; angiography&nbsp; in&nbsp; asymptomatic individuals with diabetes mellitus: Systematic review and meta-analysis. J Cardiovasc Comput Tomogr2018;12:320-28.</li>
    <li>Takx RA, Blomberg BA, El Aidi H, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive&nbsp; coronary&nbsp; angiography&nbsp; with&nbsp; fractional&nbsp; flow&nbsp; reserve&nbsp; meta-analysis.&nbsp; Circ&nbsp; Cardiovasc&nbsp; Imaging2015;8:1-7.</li>
    <li>Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA2009;301:1547-55.</li>
    <li>Zellweger MJ, Maraun M, Osterhues HH, et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging2014;7:1001-10.</li>
    <li>Budoff MJ,&nbsp; Raggi&nbsp; P,&nbsp; Beller&nbsp; GA,&nbsp; et&nbsp; al.&nbsp; Noninvasive&nbsp; Cardiovascular&nbsp; Risk&nbsp; Assessment&nbsp; of&nbsp; the&nbsp; Asymptomatic&nbsp; Diabetic&nbsp; Patient:&nbsp; The&nbsp; Imaging&nbsp; Council&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2016;9:176-92.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&nbsp; Appropriateness&nbsp; Criteria&reg;&nbsp; Radiation&nbsp; Dose&nbsp; Assessment&nbsp; Introduction.&nbsp; Available&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; https://www.acr.org/-/media/ACR/Files/Appropriateness-Criteria/RadiationDoseAssessmentIntro.pdf. Accessed September 30, 2020.</li>
</ol>

</html>